The invention relates to compounds of general formula (I), in which: R is an amino or guanidino group; R
2
is acetyl or trifluoroacetyl; n and q are either the same or different and selected from 0, 1 or 2; and X is an optionally substituted phenyl, optionally substituted naphthyl or optionally substituted phenyl-Y-optionally substituted phenyl in which Y is selected from a covalent bond, CH
2
, CH
2
CH
2
, O or SO
2
, or a pharmaceutically acceptable derivative thereof, with the proviso that when X is phenyl or naphthyl, n and q are both 2 and when X is phenyl-Y-phenyl in which Y is a covalent bond, then n and q are not both 0, methods for their preparation, pharmaceutical formulations containing them or their use in the prevention or treatment of a viral infection.
本发明涉及通式(I)的化合物,其中:R 是
氨基或
胍基; R
2
是乙酰基或三
氟乙酰基;n 和 q 可以相同或不同,选自 0、1 或 2;X 是任选取代的苯基、任选取代的
萘基或任选取代的苯基-Y-任选取代的苯基,其中 Y 选自共价键、CH
2
、CH
2
CH 2
2
O 或 SO
2
或其药学上可接受的衍
生物,但当 X 为苯基或
萘基时,n 和 q 均为 2;当 X 为苯基-Y-苯基(其中 Y 为共价键)时,则 n 和 q 均不为 0。